Evidence map›Paper›PMID 23608731›Full record

ArticleThe Journal of allergy and clinical immunology2013

High prevalence of eosinophilic esophagitis in patients with inherited connective tissue disorders.

J Pablo Abonia, Ting Wen, Emily M Stucke, Tommie Grotjan, Molly S Griffith, Katherine A Kemme, Margaret H Collins, Philip E Putnam, James P Franciosi, Karl F von Tiehl and 5 more

2 registry-linked trialsOpen access · greenAbstract read
In one paragraph

Article in The Journal of allergy and clinical immunology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 98 papers.

0numbers the graph read from it
0cells of the map it votes in
98citing papers in PubMed
13.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03822325 active not recruitingnot on this map

Inflammatory Mediators as Potential Non-Invasive Biomarkers and Understanding the Mechanism of Remodeling in Tissue Biopsies in Subjects With Eosinophilic Esophagitis: A Pilot Study

Typeobservational_patient_registrySponsorAnn & Robert H Lurie Children's Hospital of ChicagoRan2011 to 2027Enrolled88ConditionsEosinophilic Esophagitis
NCT05199532 recruitingnot on this mapstarted 2020, after this paper: background citation

Eosinophilic Gastrointestinal Disorders Registry

Typeobservational_patient_registrySponsorAnn & Robert H Lurie Children's Hospital of ChicagoRan2020 to 2035Enrolled500ConditionsEosinophilic Esophagitis, Eosinophilic Gastroenteritis, Eosinophilic Colitis, Eosinophilic Gastrointestinal Disease
3 · Its place in the literature

Who cites it

98 citing papers in PubMed, 191 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Eosinophilic gastrointestinal diseases.Nature reviews. Disease primers · 2026
    Review
  5. Article
  6. Review
  7. The oesophagus as an immune organ.Nature reviews. Gastroenterology & hepatology · 2025
    Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Mast cell activation syndrome: Current understanding and research needs.The Journal of allergy and clinical immunology · 2024
    Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Current and Novel Therapies for Eosinophilic Gastrointestinal Diseases.International journal of molecular sciences · 2023
    Review

38 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 1 country.

J Pablo AboniaDivision of Allergy and Immunology, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio 45229, USA.
Ting Wen
Emily M Stucke
Tommie Grotjan
Molly S Griffith
Katherine A Kemme
Margaret H Collins
Philip E Putnam
James P Franciosi
Karl F von Tiehl
Brad T Tinkle
Keith A Marsolo
Lisa J Martin
Stephanie M Ware
Marc E Rothenberg
Cincinnati Children's Hospital Medical Center · USUniversity of Cincinnati · USAdvocate Health Care · USNemours Children's Clinic · US

Funding

TSLP, IL-9-producing mucosal mast cells, and allergic inflammationU19AI070235 · NIAID · CINCINNATI CHILDRENS HOSP MED CTR · PI Jocelyn M Biagini · 2006 to 2026
$31.3M
Stem Cell/Organoid and Genome Editing CoreP30DK078392 · NIDDK · CINCINNATI CHILDRENS HOSP MED CTR · PI Kathryn Ann Wikenheiser-Brokamp · 2007 to 2026
$24.4M
Cincinnati Center for Clinical and Translational Sciences and TrainingUL1TR000077 · NCATS · UNIVERSITY OF CINCINNATI · PI HEUBI, JAMES E., TSEVAT, JOEL · 2012 to 2014
$9.9M
REGULATION OF GASTROINTESTINAL EOSINOPHILSR01AI045898 · NIAID · CINCINNATI CHILDRENS HOSP MED CTR · PI ROTHENBERG, MARC E. · 1999 to 2024
$4.5M
Cincinnati Center for Excellence in Molecular HematologyP30DK090971 · NIDDK · CINCINNATI CHILDRENS HOSP MED CTR · PI ZHENG, YI · 2010 to 2015
$4.0M
Regulation of Gastrointestinal EosinophilsR37AI045898 · NIAID · CINCINNATI CHILDRENS HOSP MED CTR · PI ROTHENBERG, MARC E. · 2010 to 2019
$3.6M
IL-13 Associated Eosinophil Lung ResponsesR01AI083450 · NIAID · CINCINNATI CHILDRENS HOSP MED CTR · PI ROTHENBERG, MARC E. · 2009 to 2013
$1.9M
NCATS NIH HHS UL1 TR000077NIAID NIH HHS AI045898NIAID NIH HHS R01 AI045898NIAID NIH HHS R01 AI083450NIAID NIH HHS R01AI083450NIAID NIH HHS R37 AI045898NIAID NIH HHS U19 AI070235NIDDK NIH HHS P30 DK078392NIDDK NIH HHS P30 DK090971
6 · The paper itself

Abstract

backgroundEosinophilic esophagitis (EoE) is an emerging chronic inflammatory disease mediated by immune hypersensitization to multiple foods and strongly associated with atopy and esophageal remodeling.

objectiveWe provide clinical and molecular evidence indicating a high prevalence of EoE in patients with inherited connective tissue disorders (CTDs).

methodsWe examined the rate of EoE among patients with CTDs and subsequently analyzed esophageal mRNA transcript profiles in patients with EoE with or without CTD features.

resultsWe report a cohort of 42 patients with EoE with a CTD-like syndrome, representing 0.8% of patients with CTDs and 1.3% of patients with EoE within our hospital-wide electronic medical record database and our EoE research registry, respectively. An 8-fold risk of EoE in patients with CTDs (relative risk, 8.1; 95% confidence limit, 5.1-12.9; χ(2)1 = 112.0; P < 10(-3)) was present compared with the general population. Esophageal transcript profiling identified a distinct subset of genes, including COL8A2, in patients with EoE and CTDs.

conclusionThere is a remarkable association of EoE with CTDs and evidence for a differential expression of genes involved in connective tissue repair in this cohort. Thus, we propose stratification of patients with EoE and CTDs into a subset referred to as EoE-CTD.

Indexed as

AdolescentChildChild, PreschoolCollagen Type VIIIConnective Tissue DiseasesEhlers-Danlos SyndromeEosinophilic EsophagitisEsophagusFemaleHumansMaleMarfan SyndromePrevalenceRNA, MessengerCOL8A2 protein, humanCollagen Type VIIIRNA, MessengerBMIBody mass indexCCHMCCincinnati Children's Hospital Medical CenterConnective tissue disorderconnective tissue disordersCTDEDSEGIDEhlers-Danlos syndromeElectronic medical recordEMREoEeosinophilEosinophilic esophagitiseosinophilic gastrointestinal diseaseEosinophilic gastrointestinal disorderFBN1Fibrillin-1 geneGastroesophageal reflux diseaseGERDhypermobility syndromei2b2Informatics for Integrating Biology & the BedsideJHSJoint hypermobility syndromeLDSLoeys-Dietz syndromeMarfan syndromeMFSPPIProton pump inhibitor

Identifiers

PMID23608731
PMCPMC3807809
OpenAlexW1997349413

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.